Hand-foot syndrome is a side effect of certain cancer treatments that causes pain, redness, swelling, and skin damage on the palms of your hands and soles of your feet. Its medical name is palmar-plantar erythrodysesthesia, and symptoms typically appear two to three weeks after chemotherapy begins. The condition ranges from mild tingling to severe blistering that can interfere with daily activities like walking, gripping objects, or getting dressed.
Why Hands and Feet Are Affected
Your fingertips and the soles of your feet have an unusually high concentration of tiny blood vessels called capillaries. Unlike larger blood vessels that have thick, multilayered walls, capillary walls are only a single cell thick. When chemotherapy drugs circulate through your bloodstream, they leak through these thin capillary walls and accumulate in the surrounding skin tissue at high concentrations.
Once trapped in the skin, the drug interacts with metals naturally present there to produce molecules that damage skin cells. Those damaged cells release a cascade of inflammatory signals, which in turn trigger more cell death and break down structural proteins that hold skin together. The result is a cycle of inflammation and tissue damage concentrated right where your capillaries are densest. Drugs that stay active in the bloodstream longer tend to cause more severe symptoms, because they pass through these capillaries more frequently and in greater amounts.
Which Treatments Cause It
Two distinct versions of this condition exist, depending on the type of cancer drug involved. Classic hand-foot syndrome is triggered by traditional chemotherapy agents, most commonly capecitabine, 5-fluorouracil, pegylated liposomal doxorubicin, docetaxel, cytarabine, and tegafur.
A related but slightly different condition called hand-foot skin reaction is caused by targeted therapies, including sorafenib, sunitinib, axitinib, cabozantinib, regorafenib, and several others. The targeted-therapy version tends to produce thick calluses and painful blisters at specific pressure points on the hands and feet, rather than the more diffuse redness and peeling seen with traditional chemotherapy. Both versions share the core symptoms of numbness, tingling, burning pain, and sensitivity to touch.
How Symptoms Progress
The earliest signs are usually tingling or a pins-and-needles sensation in your palms and soles. This can start as soon as a few days into treatment, though two to three weeks is more typical for traditional chemotherapy. The targeted-therapy version tends to show up within the first two to four weeks.
As the condition advances, you may notice visible skin changes. If you have lighter skin, this often looks like a sunburn-like redness on your palms and soles. If you have darker skin, the change may appear as darkening of those areas rather than redness. Swelling follows, often most noticeable in the pads of your fingertips, and the skin starts to feel tight, tender, or outright painful.
In more advanced stages, the skin can begin peeling, cracking, or blistering. Bleeding from cracked skin is possible. At its worst, the pain becomes severe enough to make it difficult to hold objects, wear shoes, or perform basic self-care tasks.
Severity Grades
Oncology teams classify hand-foot syndrome into three grades that guide treatment decisions:
- Grade 1: Minimal skin changes like mild redness, slight swelling, or skin thickening, with no pain. You can carry on with your normal routine.
- Grade 2: Skin peeling, blisters, bleeding, or more significant swelling, now accompanied by pain. Daily tasks like cooking, typing, or using tools become difficult.
- Grade 3: Severe versions of the same skin changes with significant pain. Basic self-care activities like bathing, dressing, or feeding yourself are affected.
These grades matter because they directly influence whether your cancer treatment continues at the same dose. For targeted therapies, a persistent grade 2 or any grade 3 reaction typically means treatment is paused until symptoms improve to grade 1 or resolve completely. When treatment resumes, the dose is usually lowered. Similar adjustments apply to traditional chemotherapy drugs.
Managing Symptoms at Home
Reducing friction and heat exposure are the two most important things you can do on your own. Wear loose-fitting, soft-soled shoes and avoid going barefoot. Choose socks without tight seams. On your hands, avoid activities that press hard against the skin, like gripping tools, opening jars, or extended typing sessions. Keep water temperature lukewarm when washing dishes or bathing, since hot water worsens symptoms.
Moisturizing is critical. Urea-based creams applied two to three times a day help keep the skin barrier intact. Products containing 10 to 40 percent urea are commonly recommended, and widely available options include Udderly Smooth Extra Care 20 and Eucerin UreaRepair Plus. Apply gently rather than rubbing vigorously, since friction itself can aggravate the skin. If you have any pre-existing skin conditions on your hands or feet, such as calluses, fungal infections, or eczema, getting those treated before starting chemotherapy can reduce your risk.
Medical Treatments
When home care isn’t enough, several prescription options can help. A topical anti-inflammatory gel applied to the hands and feet twice daily can reduce pain and inflammation at the skin surface. For more significant swelling and pain, your oncologist may prescribe a stronger anti-inflammatory medication taken by mouth or a potent prescription steroid cream applied directly to the affected areas.
Pain management is also part of the picture. If over-the-counter pain relief isn’t cutting it, prescription options are available. The goal is to keep you comfortable enough to continue your cancer treatment at the most effective dose possible, since dose reductions or treatment pauses can affect how well the therapy works against your cancer.
Cooling During Infusions
One prevention strategy that has shown promise is cooling your hands and feet during the actual chemotherapy infusion. This involves applying ice packs, immersing extremities in ice water, or wearing frozen gloves and socks while the drug is being administered. The idea is that cold narrows blood vessels, reducing how much drug reaches the skin.
Results have been mixed across studies, but one prospective study of 53 patients receiving a combination chemotherapy regimen found a striking difference: only 7% of patients who used ice packs on their hands and feet developed hand-foot syndrome, compared to 36% of those who did not. If your treatment center offers cooling during infusions, it’s worth discussing with your care team.
What Recovery Looks Like
Hand-foot syndrome is reversible. Symptoms typically begin improving within one to two weeks after a treatment pause or dose reduction, and skin gradually heals as the drug clears your system. The peeling and blistering resolve first, followed by the tenderness and sensitivity. During recovery, continuing to moisturize and protect the skin from friction helps speed the process. If your treatment plan calls for resuming chemotherapy, your team will wait until symptoms have dropped to at least grade 1 before restarting, usually at a lower dose to prevent recurrence at the same severity.